Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about neuroinflammation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A mechanism referenced in 1 knowledge graph relationship. Key connections: contributes_to alzheimers (disease).
| Name | Neuroinflammation PET Imaging in CBS/PSP |
| Summary | PET imaging of neuroinflammation in corticobasal syndrome and progressive supranuclear palsy - TSPO, microglial activation, MAO-B imaging, and MRS |
| Key Genes/Proteins | NLRP3, STING, RIPK1, TREM2, ACOD1, IL1B |
| Related Diseases | neuronal damage, Parkinson's Disease, Multiple Sclerosis, A1 astrocyte phenotype |
| Related Pathways | NF-κB, cGAS-STING-NF-κB signaling, NF-κB pathway |
| Linked Hypotheses | 6 hypotheses |
Knowledge base pages for this entity
graph TD
Trigger["Pathology Trigger"] -->|"Activates"| Microglia["Microglia"]
Trigger -->|"Activates"| Astrocytes["Astrocytes"]
Microglia -->|"Release"| Cytokines["Pro-inflammatory Cytokines"]
Astrocytes -->|"Release"| Reactivity["Reactive Molecules"]
Cytokines -->|"Include"| TNF["TNF-alpha, IL-1beta, IL-6"]
Reactivity -->|"Include"| ROS["ROS, NO"]
TNF -->|"Amplify"| Inflammation["Chronic Inflammation"]
ROS -->|"Cause"| Damage["Oxidative Damage"]
Inflammation -.Contributes to.-> Neurodegeneration["Neurodegeneration"]| Target | Relation | Type | Str |
|---|---|---|---|
| neuronal damage | causes | phenotype | 0.95 |
| Parkinson's Disease | drives | disease | 0.95 |
| Multiple Sclerosis | drives | disease | 0.95 |
| neurodegeneration | promotes | process | 0.90 |
| depression | causes | disease | 0.90 |
| spinal cord | affects | brain_region | 0.90 |
| ferroptosis | involves | pathway | 0.90 |
| purinergic receptor | involves | receptor | 0.90 |
| cGAS-STING | involves | pathway | 0.90 |
| neuronal damage | contributes_to | process | 0.90 |
| midbrain | involved_in | brain_region | 0.90 |
| neurodegeneration | contributes_to | process | 0.90 |
| neurodegeneration | drives | process | 0.90 |
| cortex | affects | brain_region | 0.90 |
| astrocytes | affects | cell_type | 0.90 |
| microglia | affects | cell_type | 0.90 |
| macrophages | affects | cell_type | 0.90 |
| NF-kB signaling | involves | pathway | 0.90 |
| neurons | affects | cell_type | 0.90 |
| unfolded protein response | involves | pathway | 0.90 |
| lipid metabolism | involves | pathway | 0.90 |
| oligodendrocytes | affects | cell_type | 0.90 |
| PI3K-AKT-mTOR signaling | involves | pathway | 0.90 |
| blood-brain barrier | affects | brain_region | 0.90 |
| dopaminergic neurons | affects | cell_type | 0.90 |
| hippocampus | affects | brain_region | 0.90 |
| pyroptosis | involves | pathway | 0.90 |
| MAPK signaling | involves | pathway | 0.90 |
| synaptic plasticity | involves | pathway | 0.90 |
| JAK-STAT signaling | involves | pathway | 0.90 |
| neural stem cells | affects | cell_type | 0.90 |
| oxidative stress | causes | process | 0.90 |
| dopaminergic neurons | causes | cell_type | 0.90 |
| blood-brain barrier | associated_with | brain_region | 0.90 |
| Alzheimer's Disease | associated_with | disease | 0.90 |
| Alzheimer's Disease | causes | disease | 0.90 |
| Parkinson's Disease | causes | disease | 0.90 |
| dopaminergic neurodegeneration | contributes_to | process | 0.88 |
| secondary brain injury | contributes_to | disease | 0.88 |
| Alzheimer's Disease | contributes_to | disease | 0.88 |
| depression | promotes | disease | 0.85 |
| cognitive decline | promotes | phenotype | 0.85 |
| circadian regulation | involves | pathway | 0.85 |
| Alzheimer's Disease | drives | disease | 0.85 |
| Parkinson's Disease | contributes_to | disease | 0.85 |
| inhibitory synaptic transmission | inhibits | process | 0.84 |
| neurodegenerative diseases | promotes | disease | 0.82 |
| calcium signaling | involves | pathway | 0.80 |
| white matter | affects | brain_region | 0.80 |
| glutamate signaling | involves | pathway | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NLRP3 | promotes | protein | 0.95 |
| STING | promotes | protein | 0.95 |
| RIPK1 | regulates | protein | 0.95 |
| DAMPs | associated_with | compound | 0.95 |
| TREM2 | mediates | gene | 0.95 |
| mitochondrial dysfunction | drives | process | 0.95 |
| NF-κB | activates | pathway | 0.95 |
| cGAS-STING-NF-κB signaling | promotes | pathway | 0.94 |
| ACOD1 | inhibits | gene | 0.94 |
| NF-κB pathway | promotes | pathway | 0.93 |
| A1 astrocyte phenotype | associated_with | phenotype | 0.92 |
| IL1B | promotes | protein | 0.92 |
| TNF-α | promotes | protein | 0.92 |
| defective mitophagy | causes | phenotype | 0.90 |
| TREM1 | causes | protein | 0.90 |
| NLRP3 | associated_with | gene | 0.90 |
| APOE4 | promotes | gene | 0.90 |
| NLRP3 inflammasome | promotes | pathway | 0.90 |
| T3 (triiodothyronine) | inhibits | drug | 0.90 |
| E4A | prevents | drug | 0.90 |
| skeletal muscle | regulates | cell_type | 0.90 |
| ADK | promotes | protein | 0.90 |
| H-EV | inhibits | drug | 0.90 |
| type I interferon response | promotes | process | 0.90 |
| APOE ε2 | improves | gene | 0.90 |
| TREM2 | activates | gene | 0.90 |
| GFAP | activates | gene | 0.90 |
| NLRP3 | inhibits | gene | 0.90 |
| NLRP3 | regulates | gene | 0.90 |
| STING | activates | gene | 0.90 |
| BDNF | inhibits | gene | 0.90 |
| IL-6 deficiency | inhibits | process | 0.90 |
| NLRP3 | plays_crucial_role | protein | 0.90 |
| PARTHANATOS | plays_pivotal_role | process | 0.90 |
| TBK1 | does_not_cause | gene | 0.90 |
| choroid plexus | synergizes_with | tissue | 0.90 |
| GPR34 | promotes | protein | 0.90 |
| oligodendrocyte | drives | cell_type | 0.90 |
| cysteinyl leukotrienes | mediates | compound | 0.90 |
| ALOX5 pathway | regulates | pathway | 0.90 |
| NLRP3 | drives | protein | 0.90 |
| SASP | promotes | process | 0.90 |
| IL1B | drives | protein | 0.90 |
| Lgals3 | drives | protein | 0.90 |
| lipopolysaccharide | associated_with | compound | 0.90 |
| cytokine/chemokine network | associated_with | pathway | 0.90 |
| chemokines | regulates | protein | 0.90 |
| autophagy | modulates | process | 0.90 |
| NLRP3 inflammasome | drives | protein | 0.90 |
| Jak/Stat | activates | pathway | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone | 0.645 | neurodegeneration | What are the precise temporal dynamics o |
| STING Antagonism Prevents Acute-to-Chronic Neuroinflammation | 0.605 | neuroinflammation | What molecular mechanisms drive the tran |
| Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 | 0.601 | neurodegeneration | What are the mechanisms by which gut mic |
| Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio | 0.486 | translational neuroscience | Which metabolic biomarkers can distingui |
| Cardiovascular-Neuroinflammation Crosstalk Interruption | 0.437 | Alzheimer's disease | Neuroinflammation and microglial priming |
Scientific analyses that reference this entity
neuroinflammation | 2026-04-15 | 2 hypotheses Top: 0.605
neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.567
neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.596
neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.632
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.473
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for S [PMID:41114949] | Ding YN, Li MQ, Ding PT, Wang P, Guan PP | Nano letters | 2026 | 1 |
| Systemic inflammation as a central player in the initiation and development of A [PMID:40841660] | Bayraktaroglu I, Ortí-Casañ N, Van Dam D | Immunity & ageing : I & A | 2025 | 1 |
| Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibi [PMID:40050873] | Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding | Journal of nanobiotechnology | 2025 | 1 |
| Interactions between antidiabetes medications and heart-brain axis. [PMID:39639832] | Ong LT, Sia CH | Current opinion in endocrinolo | 2025 | 1 |
| The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Rev [PMID:40507911] | Popa E, Popa AE, Poroch M, Poroch V, Ung | International journal of molec | 2025 | 1 |
| Air pollution, glymphatic impairment, and Alzheimer's disease. [PMID:37777345] | Hussain R, Graham U, Elder A, Nedergaard | Trends in neurosciences | 2023 | 0 |
| Molecular biomarkers for vascular cognitive impairment and dementia. [PMID:37957261] | Hosoki S, Hansra GK, Jayasena T, Poljak | Nature reviews. Neurology | 2023 | 0 |